Peter Eckes, Former CTO of BASF Agricultural Solutions, to Chair Harpe Bioherbicide Board

Dr. Peter Eckes

Harpe Bioherbicide Solutions, Inc., an agricultural technology company focused on providing natural and sustainable herbicide solutions, announced today that Dr. Peter Eckes, former President of BASF leading Crop Protection R&D, Seed and Trait R&D and Regulatory in the Agricultural Solutions division, has joined its board and will serve as board chairperson.

Bill Buckner, CEO of Harpe Bioherbicide

“We’re thrilled to bring Peter’s vast, global experience developing and delivering innovation to our mission of creating new, natural weed control options for farmers and consumers.”

Through more than a 30-year career in the agricultural industry, Dr. Peter Eckes provides a unique appreciation for what it takes to bring innovation to the modern agriculture marketplace at scale without losing sight of farmer and consumer needs.

“Harpe has both a compelling value proposition and strong business plan to bring new and natural weed control innovations to life,” said Eckes. “I look forward to supporting and accelerating Harpe’s efforts to meet the critical need for the next generation of weed control and consumer demands for more natural inputs.”

Eckes assumes board leadership from Aidan J. Connolly, President of AgriTech Capital, who will remain as a Harpe Bioherbicide board member.

“As important as it is for a start-up to have a laser focus, fresh perspectives can make all the difference in the world,” said Connolly. “I’m working closely with Peter to ensure we make the most of his leadership and build on the momentum Harpe has achieved.”

Additional Board Members

Additional Harpe Bioherbicide board members include CEO Buckner; Kip Tom, CEO of Tom Farms and former UN Ambassador; Robb Fraley, former CTO for Monsanto Co.; Chad Brommer, Harpe Bioherbicide co-founder and CTO; and Daniel Pepitone, Harpe Bioherbicide co-founder and COO.

In addition to serving as Board chair, Eckes will lead the company’s scientific advisory committee, which includes Adrian Percy, Executive Director of the N.C. Plant Sciences Initiative at North Carolina State University; Stephen Powles, Professor at University of Western Australia; and Wesley Everman, Associate Professor and Extension Weed Specialist at North Carolina State University.

Through wide-spectrum control of broadleaf and grass seeds or weeds, the platform of Harpe Bioherbicide products will deliver new opportunities for organic agriculture through a series of all natural herbicide formulations for pre, post and desiccation use patterns. In addition, a series of tailored Harpe Bioherbicide pre and tank mix formulations will improve control of tough-to-kill weeds, including those resistant to current synthetic chemistries, facilitating the reduction, replacement, and enhancement of synthetic herbicides used in row and specialty crop, and commercial markets.

This year’s BioAgTech World Congress will be in Raleigh, April 23-26. 2024. Harpe is a candidate for the BioAgTech Innovator Award and World Congress Wi-Fi sponsor. Approximately 1300 attendees from 250 companies and 60 countries will be in attendance. Those attending are invited to visit Booth #22 to learn more about Harpe Bioherbicide formulations.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version